神経学臨床試験の世界市場：市場規模・シェア・動向分析 (フェーズ別、試験設計別、適応症別、バリューチェーン別、地域別)、セグメント別予測 (2025年～2030年)

神経学臨床試験市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の神経学臨床試験市場規模は2030年までに84億2,000万米ドルに達し、2025年から2030年までのCAGRは6.39％を記録すると推定されています。

これは、大手製薬会社が神経科学分野で革新的な臨床試験を実施していること、米国国立神経疾患・脳卒中研究所（NINDS）からの政府助成金が増加していること、世界的に神経疾患の有病率が高いことが主な要因です。

神経科学は健全な投資を受け続けています。例えば、2022年11月、NRG Therapeutics社は、筋萎縮性側索硬化症（ALS）やパーキンソン病などの神経変性疾患を治療するミトコンドリア治療薬の開発のため、1,830万米ドルのシリーズA資金を調達しました。今後も同様の取り組みが採用されることで、市場の成長が期待されます。

世界中で相当数の人々が神経疾患に苦しんでいます。例えば、Parkinson's Foundationの統計によると、毎年6万人の米国人がPDと診断され、世界中で1,000万人以上の人々がこの病気と共存しています。てんかんに関しては、WHOは世界中で6,500万人以上がてんかんに罹患していると発表しています。この疾患は低・中所得国で最も多く、てんかん患者の80.0%を占めています。神経疾患の有病率の高さが臨床試験の需要を押し上げ、市場を支えるものと期待されています。

神経学は、臨床試験が実施される主要分野の1つと考えられています。Pharma R&D Annual Reviewによると、2021年、神経学臨床試験は、臨床試験が主に行われる3番目の分野でした。Pharma R&D Annual Reviewによると、神経学領域では2,900以上の医薬品が治験中であり、2022年には3,200以上の医薬品が治験中でした。神経領域で臨床試験を開始する薬剤の増加は、パンデミック後の市場を下支えすると予想されます。

神経学臨床試験市場：分析概要

• フェーズ別では、フェーズIIが市場を独占し、2024年には42.14%の最大売上シェアを占めました。神経学臨床試験の大半は現在フェーズ2にあり、これが同セグメント市場を支えています。
• 試験設計別では、インターベンショナル・セグメンテーションが2024年に最大の市場売上シェアを占めました。この試験デザインで実施される神経学臨床試験の数が多いことが、同セグメント市場の成長を促進しています。
• 適応症別では、ハンチントン病分野が予測期間中に大きなCAGRを記録すると予測されています。これは、ハンチントン病に使用される医薬品に対する需要が世界的に高いという事実によるところが大きいです。
• 北米が市場を独占し、2024年には46.96%の売上シェアを占めました。神経疾患の有病率が上昇し、臨床試験に多くの企業が参加していることが、この地域の市場を牽引しています。これらが高い市場シェアの主な理由です。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 神経学臨床試験市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
  • 市場機会
  • 市場の課題
• 技術情勢
• 価格モデル分析
• 研究開発費分析（2018～2024年）
• 臨床試験件数分析（2024年）
• 市場分析ツール
  • ポーターのファイブフォース分析
  • SWOT分析によるPESTEL
  • COVID-19の影響分析

第4章 神経学臨床試験市場：フェーズ別の推定・動向分析

• 神経学臨床試験市場：セグメントダッシュボード、フェーズ別
• 神経学臨床試験市場：変動分析、フェーズ別
• フェーズ別（2018年～2030年）
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

第5章 神経学臨床試験市場：試験設計別の推定・動向分析

• 神経学臨床試験市場：セグメントダッシュボード、試験設計別
• 神経学臨床試験市場：変動分析、試験設計別
• 試験設計別（2018年～2030年）
• 介入的
• 観察的
• 拡張アクセス

第6章 神経学臨床試験市場：適応症別の推定・動向分析

• 神経学臨床試験市場：セグメントダッシュボード、適応症別
• 神経学臨床試験市場：変動分析、適応症別
• 適応症別（2018年～2030年）
• 神経学臨床試験市場（適応症別）：セグメントダッシュボード
• 神経学臨床試験市場（適応症別）：変動分析
• 適応症別（2018年～2030年）
• アルツハイマー病
• うつ病（MDD）
• パーキンソン病（PD）
• てんかん
• 脳卒中
• 外傷性脳損傷（TBI）
• 筋萎縮性側索硬化症（ALS）
• ハンチントン病
• 筋肉の再生
• その他

第7章 神経学臨床試験市場：試験設計別・適応症別の推定・動向分析

• 神経学臨床試験市場、試験設計別・適応症別：セグメントダッシュボード
• 神経学臨床試験市場、試験設計別・適応症別：変動分析
• 試験設計別（2018年～2030年）
• アルツハイマー病
  • アルツハイマー病・介入
  • アルツハイマー病・観察
  • アルツハイマー病・拡大アクセス
• うつ病（MDD）
  • うつ病（MDD）・介入
  • うつ病（MDD）・観察
  • うつ病（MDD）・拡大アクセス
• パーキンソン病（PD）
  • パーキンソン病（PD）・介入
  • パーキンソン病（PD）・観察
  • パーキンソン病（PD）・拡大アクセス
• てんかん
  • てんかん・介入
  • てんかん・観察
  • てんかん・拡大アクセス
• 脳卒中
  • 脳卒中・介入
  • 脳卒中・観察
  • 脳卒中・拡大アクセス
• 外傷性脳損傷（TBI）
  • 外傷性脳損傷（TBI）・介入
  • 外傷性脳損傷（TBI）・観察
  • 外傷性脳損傷（TBI）・拡大アクセス
• 筋萎縮性側索硬化症（ALS）
  • 筋萎縮性側索硬化症（ALS）・介入
  • 筋萎縮性側索硬化症（ALS）・観察研究
  • 筋萎縮性側索硬化症（ALS）・拡大アクセス
• ハンチントン病
  • ハンチントン病・介入
  • ハンチントン病・観察
  • ハンチントン病・拡大アクセス
• 筋肉の再生
  • 筋肉再生・介入
  • 筋肉再生・観察
  • 筋肉再生・拡大アクセス
• その他
  • その他の介入
  • その他の観察
  • その他の拡張アクセス

第8章 神経学臨床試験市場：フェーズ別・適応症別の推定・動向分析

• 神経学臨床試験市場：セグメントダッシュボード、フェーズ別・適応症別
• 神経学臨床試験市場：変動分析、フェーズ別・適応症別
• フェーズ別（2018年～2030年）
• アルツハイマー病
  • アルツハイマー病・フェーズI
  • アルツハイマー病・フェーズII
  • アルツハイマー病・フェーズIII
  • アルツハイマー病・フェーズIV
• うつ病（MDD）
  • うつ病（MDD）・フェーズI
  • うつ病（MDD）・フェーズIII
  • うつ病（MDD）・フェーズIII
  • うつ病（MDD）・フェーズIV
• パーキンソン病（PD）
  • パーキンソン病（PD）・フェーズI
  • パーキンソン病（PD）・フェーズII
  • パーキンソン病（PD）・フェーズIII
  • パーキンソン病（PD）・フェーズIV
• てんかん
  • てんかん・フェーズI
  • てんかん・フェーズII
  • てんかん・フェーズIII
  • てんかん・フェーズIV
• 脳卒中
  • 脳卒中・フェーズI
  • 脳卒中・フェーズII
  • 脳卒中・フェーズIII
  • 脳卒中・フェーズIV
• 外傷性脳損傷（TBI）
  • 外傷性脳損傷（TBI）・フェーズI
  • 外傷性脳損傷（TBI）・フェーズII
  • 外傷性脳損傷（TBI）・フェーズIII
  • 外傷性脳損傷（TBI）・フェーズIV
• 筋萎縮性側索硬化症（ALS）
  • 筋萎縮性側索硬化症（ALS）・フェーズI
  • 筋萎縮性側索硬化症（ALS）・フェーズII
  • 筋萎縮性側索硬化症（ALS）・フェーズIII
  • 筋萎縮性側索硬化症（ALS）・フェーズIV
• ハンチントン病
  • ハンチントン病・フェーズI
  • ハンチントン病・フェーズII
  • ハンチントン病・フェーズIII
  • ハンチントン病・フェーズIV
• 筋肉再生
  • 筋肉再生・フェーズI
  • 筋肉再生・フェーズII
  • 筋肉再生・フェーズIII
  • 筋肉再生・フェーズIV
• その他
  • その他・フェーズI
  • その他・フェーズII
  • その他・フェーズIII
  • その他・フェーズIV

第9章 神経学臨床試験市場：バリューチェーン別の推定・動向分析

• 神経学臨床試験市場：セグメントダッシュボード、バリューチェーン別
• 神経学臨床試験市場：変動分析、バリューチェーン別
• バリューチェーン別（2018年～2030年）
• 社内
• CRO
• 治験実施施設/臨床施設

第10章 神経学臨床試験市場：地域別の推定・動向分析

• 市場ダッシュボード：地域別
• 市場シェア：地域別 (2024年・2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • タイ
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

List of Tables

• Table 1. List of Tables
• Table 2. List of Secondary Sources
• Table 3. List of Abbreviations
• Table 4. Global Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 5. Global Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 6. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 7. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 8. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 9. Global Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 10. Global Neurology Clinical Trials Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
• Table 11. North America Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 12. North America Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 13. North America Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 14. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 15. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 16. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 17. North America Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 18. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 19. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 20. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 21. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 22. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 23. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 24. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 25. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 26. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 27. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 28. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 29. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 30. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 31. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 32. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 33. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 34. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 35. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 36. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 37. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 38. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 39. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 40. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 41. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 42. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 43. UK Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 44. UK Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 45. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 46. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 47. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 48. UK Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 49. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 50. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 51. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 52. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 53. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 54. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 55. France Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 56. France Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 57. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 58. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 59. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 60. France Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 61. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 62. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 63. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 64. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 65. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 66. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 67. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 68. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 69. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 70. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 71. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 72. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 73. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 74. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 75. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 76. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 77. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 78. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 79. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 80. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 81. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 82. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 83. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 84. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 85. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 86. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 87. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 88. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 89. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 90. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 91. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 92. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 93. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 94. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 95. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 96. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 97. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 98. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 99. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 100. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 101. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 102. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 103. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 104. China Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 105. China Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 106. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 107. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 108. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 109. China Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 110. India Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 111. India Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 112. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 113. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 114. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 115. India Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 116. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 117. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 118. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 119. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 120. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 121. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 122. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 123. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 124. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 125. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 126. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 127. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 128. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 129. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 130. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 131. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 132. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 133. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 134. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 135. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 136. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 137. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 138. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 139. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 140. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 141. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 142. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 143. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 144. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 145. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 146. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 147. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 148. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 149. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 150. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 151. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 152. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 153. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 154. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 155. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 156. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 157. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 158. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 159. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 160. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 161. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 162. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 163. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 164. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 165. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 166. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 167. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 168. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 169. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 170. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 171. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 172. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 173. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 174. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 175. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
• Table 176. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
• Table 177. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
• Table 178. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
• Table 179. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
• Table 180. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
• Table 181. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Commodity flow analysis
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD model sizing & forecasting
• Fig. 9 Bottom-up approach
• Fig. 10 Market snapshot
• Fig. 11 Segment snapshot 1
• Fig. 12 Segment snapshot 2
• Fig. 13 Competitive landscape snapshot
• Fig. 14 Parent market outlook, 2024 (USD Billion)
• Fig. 15 Ancillary market outlook, 2024 (USD Billion)
• Fig. 16 Neurology Clinical Trials Market Dynamics
• Fig. 17 Porter's five forces analysis
• Fig. 18 PESTEL analysis
• Fig. 19 Neurology Clinical Trials Market: Phase outlook and key takeaways
• Fig. 20 Neurology Clinical Trials Market: Phase movement analysis
• Fig. 21 Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Neurology Clinical Trials Market: Study design outlook and key takeaways
• Fig. 26 Neurology Clinical Trials Market: Study design movement analysis
• Fig. 27 Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Neurology Clinical Trials Market: Indication outlook and key takeaways
• Fig. 31 Neurology Clinical Trials Market: Indication movement analysis
• Fig. 32 Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Neurology Clinical Trials Market: Indication by Study Design outlook and key takeaways
• Fig. 43 Neurology Clinical Trials Market: Indication by Study Design movement analysis
• Fig. 44 Alzheimer's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Alzheimer's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Alzheimer's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Depression (MDD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Depression (MDD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Depression (MDD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Parkinson's Disease (PD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Parkinson's Disease (PD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Parkinson's Disease (PD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Epilepsy Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Epilepsy Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Epilepsy Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Stroke Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Stroke Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Stroke Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Traumatic Brain Injury (TBI) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Traumatic Brain Injury (TBI) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Traumatic Brain Injury (TBI) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Amyotrophic Lateral Sclerosis (ALS) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Amyotrophic Lateral Sclerosis (ALS) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Amyotrophic Lateral Sclerosis (ALS) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Huntington's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Huntington's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Huntington's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Muscle Regeneration Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Muscle Regeneration Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Muscle Regeneration Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Others Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Others Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Others Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Neurology Clinical Trials Market: Value Chain Design outlook and key takeaways
• Fig. 75 Neurology Clinical Trials Market: Value Chain movement analysis
• Fig. 76 In-house Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 77 CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Investigator Sites/Clinical Sites Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Regional Marketplace: Key Takeaways
• Fig. 80 North America Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 U.S. Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Key country dynamics
• Fig. 84 Canada Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 Mexico Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Europe Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 UK Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 Germany Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 France Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 Italy Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Key country dynamics
• Fig. 97 Spain Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Key country dynamics
• Fig. 99 Denmark Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 100 Key country dynamics
• Fig. 101 Sweden Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 102 Key country dynamics
• Fig. 103 Norway Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 104 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 105 Key country dynamics
• Fig. 106 Japan Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 107 Key country dynamics
• Fig. 108 China Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 109 Key country dynamics
• Fig. 110 India Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 111 Key country dynamics
• Fig. 112 Thailand Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 113 Key country dynamics
• Fig. 114 South Korea Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 115 Key country dynamics
• Fig. 116 Australia Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 117 Latin America Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 118 Key country dynamics
• Fig. 119 Brazil Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 120 Key country dynamics
• Fig. 121 Argentina Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 122 MEA Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 123 Key country dynamics
• Fig. 124 South Africa Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 125 Key country dynamics
• Fig. 126 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 127 Key country dynamics
• Fig. 128 UAE Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 129 Key country dynamics
• Fig. 130 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 131 Key company categorization
• Fig. 132 Service heat map analysis
• Fig. 133 Strategic framework

Neurology Clinical Trials Market Growth & Trends:

The global neurology clinical trials market size is estimated to reach USD 8.42 billion by 2030, registering a CAGR of 6.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is largely attributed to big pharma companies conducting innovative trials in neurology, increased government funding from the National Institute of Neurological Disorders and Stroke (NINDS), and the high prevalence of neurological disorders worldwide.

Neuroscience continues to receive a healthy investment. For instance, in November 2022, NRG Therapeutics raised Series A funding of USD 18.3 million for the development of mitochondrial therapeutics to treat neurodegenerative ailments such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease. The adoption of similar initiatives in the future is expected to support market growth.

A significant number of people worldwide suffer from neurological disorders. For instance, as per the statistics from Parkinson's Foundation, every year 60,000 Americans are diagnosed with PD and more than 10 million people are living with the disease around the world. In terms of Epilepsy, the WHO states that more than 65 million people worldwide are affected by it. The disease is most prevalent in low- and middle-income countries, which account for 80.0% of epilepsy cases. A high prevalence of neurological disorders is expected to boost demand for clinical trials and thus support the market.

Neurology is considered as one of the major areas where clinical trials are conducted. As per the Pharma R&D Annual Review, in 2021, Neurology trials were the third area where clinical trials were majorly focused. The Pharma R&D Annual Review stated that for neurology above 2,900 drugs were under trial and in the year 2022 the number of drugs for clinical studies in the area of neurology accounted for more than 3,200 active drugs. An increasing number of drugs entering clinical trials in the area of neurology are expected to support the market in the post-pandemic period.

Neurology Clinical Trials Market Report Highlights:

• By phase, the phase II segment dominated the market and accounted for a maximum revenue share of 42.14% in 2024. A majority number of neurology clinical trials are currently in Phase 2, this is supporting the segment market.
• By study design, the interventional segment held the largest market revenue share of in 2024. A high number of neurology clinical trials conducted through this study design type is promoting the growth of the segment market.
• By indication, the Huntington's disease segment is anticipated to register the significant CAGR over the forecast period. This is largely due to the fact that there is a high demand for the medicines used for Huntington's disease worldwide as there are no medications available for treating this disease.
• North America dominated the market and accounted for a revenue share of 46.96% in 2024. The rising prevalence of neurological disorders and the presence of a large number of players in clinical trials drive the market in the region. These are some of the key reasons for the high market share.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Study Design
  • 1.2.2. Indication
  • 1.2.3. Indication by Study Design
  • 1.2.4. Indication by Phase
  • 1.2.5. Value Chain
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Neurology Clinical Trials Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of neurological diseases such as Alzheimer disease, epilepsy, and stroke
    • 3.2.1.2. Growing adoption of novel technologies in clinical research
    • 3.2.1.3. Substantial number of CROs providing neurology clinical research services
    • 3.2.1.4. Increasing funding for neurological studies by public organizations
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost associated with neurology clinical studies
    • 3.2.2.2. High failure rate coupled with patient dropout issues associated with neurological clinical trials
  • 3.2.3. Market Challenges
  • 3.2.4. Market Opportunities
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. R&D Spending Analysis (2018-2024)
• 3.6. Clinical Trial Volume Analysis, 2024
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Force Analysis
  • 3.7.2. PESTEL by SWOT Analysis
  • 3.7.3. COVID-19 Impact Analysis

Chapter 4. Neurology Clinical Trials Market: Phase Estimates & Trend Analysis

• 4.1. Neurology Clinical Trials Market, By Phase: Segment Dashboard
• 4.2. Neurology Clinical Trials Market, By Phase: Movement Analysis
• 4.3. Neurology Clinical Trials Market Estimates & Forecasts, By Phase, 2018 - 2030 (USD Million)
• 4.4. Phase I
  • 4.4.1. Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Phase II
  • 4.5.1. Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Phase III
  • 4.6.1. Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Phase IV
  • 4.7.1. Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurology Clinical Trials Market: Study Design Estimates & Trend Analysis

• 5.1. Neurology Clinical Trials Market, By Study Design: Segment Dashboard
• 5.2. Neurology Clinical Trials Market, By Study Design: Movement Analysis
• 5.3. Neurology Clinical Trials Market Estimates & Forecasts, By Study Design, 2018 - 2030 (USD Million)
• 5.4. Interventional
  • 5.4.1. Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Observational
  • 5.5.1. Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Expanded Access
  • 5.6.1. Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurology Clinical Trials Market: Indication Estimates & Trend Analysis

• 6.1. Neurology Clinical Trials Market, By Indication: Segment Dashboard
• 6.2. Neurology Clinical Trials Market, By Indication: Movement Analysis
• 6.3. Neurology Clinical Trials Market Estimates & Forecasts, By Indication, 2018 - 2030 (USD Million)
• 6.4. Alzheimer's Disease
  • 6.4.1. Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Depression (MDD)
  • 6.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Parkinson's Disease (PD)
  • 6.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Epilepsy
  • 6.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Stroke
  • 6.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Traumatic Brain Injury (TBI)
  • 6.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.10. Amyotrophic Lateral Sclerosis (ALS)
  • 6.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.11. Huntington's Disease
  • 6.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.12. Muscle Regeneration
  • 6.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.13. Others
  • 6.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Neurology Clinical Trials Market: Indication by Study Design Estimates & Trend Analysis

• 7.1. Neurology Clinical Trials Market, Indication by Study Design: Segment Dashboard
• 7.2. Neurology Clinical Trials Market, Indication by Study Design: Movement Analysis
• 7.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Study Design, 2018 - 2030 (USD Million)
• 7.4. Alzheimer's Disease
  • 7.4.1. Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. Alzheimer's Disease Interventional
    • 7.4.2.1. Alzheimer's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Alzheimer's Disease Observational
    • 7.4.3.1. Alzheimer's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Alzheimer's Disease Expanded Access
    • 7.4.4.1. Alzheimer's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Depression (MDD)
  • 7.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Depression (MDD) Interventional
    • 7.5.2.1. Depression (MDD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Depression (MDD) Observational
    • 7.5.3.1. Depression (MDD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Depression (MDD) Expanded Access
    • 7.5.4.1. Depression (MDD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Parkinson's Disease (PD)
  • 7.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Parkinson's Disease (PD) Interventional
    • 7.6.2.1. Parkinson's Disease (PD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Parkinson's Disease (PD) Observational
    • 7.6.3.1. Parkinson's Disease (PD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. Parkinson's Disease (PD) Expanded Access
    • 7.6.4.1. Parkinson's Disease (PD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Epilepsy
  • 7.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Epilepsy Interventional
    • 7.7.2.1. Epilepsy Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Epilepsy Observational
    • 7.7.3.1. Epilepsy Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. Epilepsy Expanded Access
    • 7.7.4.1. Epilepsy Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Stroke
  • 7.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. Stroke Interventional
    • 7.8.2.1. Stroke Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Stroke Observational
    • 7.8.3.1. Stroke Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. Stroke Expanded Access
    • 7.8.4.1. Stroke Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Traumatic Brain Injury (TBI)
  • 7.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. Traumatic Brain Injury (TBI) Interventional
    • 7.9.2.1. Traumatic Brain Injury (TBI) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.3. Traumatic Brain Injury (TBI) Observational
    • 7.9.3.1. Traumatic Brain Injury (TBI) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.4. Traumatic Brain Injury (TBI) Expanded Access
    • 7.9.4.1. Traumatic Brain Injury (TBI) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.10. Amyotrophic Lateral Sclerosis (ALS)
  • 7.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10.2. Amyotrophic Lateral Sclerosis (ALS) Interventional
    • 7.10.2.1. Amyotrophic Lateral Sclerosis (ALS) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10.3. Amyotrophic Lateral Sclerosis (ALS) Observational
    • 7.10.3.1. Amyotrophic Lateral Sclerosis (ALS) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10.4. Amyotrophic Lateral Sclerosis (ALS) Expanded Access
    • 7.10.4.1. Amyotrophic Lateral Sclerosis (ALS) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.11. Huntington's Disease
  • 7.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.2. Huntington's Disease Interventional
    • 7.11.2.1. Huntington's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.3. Huntington's Disease Observational
    • 7.11.3.1. Huntington's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.4. Huntington's Disease Expanded Access
    • 7.11.4.1. Huntington's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.12. Muscle Regeneration
  • 7.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.12.2. Muscle Regeneration Interventional
    • 7.12.2.1. Muscle Regeneration Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.12.3. Muscle Regeneration Observational
    • 7.12.3.1. Muscle Regeneration Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.12.4. Muscle Regeneration Expanded Access
    • 7.12.4.1. Muscle Regeneration Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.13. Others
  • 7.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.13.2. Others Interventional
    • 7.13.2.1. Others Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.13.3. Others Observational
    • 7.13.3.1. Others Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.13.4. Others Expanded Access
    • 7.13.4.1. Others Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Neurology Clinical Trials Market: Indication by Phase Estimates & Trend Analysis

• 8.1. Neurology Clinical Trials Market, Indication by Phase: Segment Dashboard
• 8.2. Neurology Clinical Trials Market, Indication by Phase: Movement Analysis
• 8.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Phase, 2018 - 2030 (USD Million)
• 8.4. Alzheimer's Disease
  • 8.4.1. Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. Alzheimer's Disease Phase I
    • 8.4.2.1. Alzheimer's Disease Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Alzheimer's Disease Phase II
    • 8.4.3.1. Alzheimer's Disease Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Alzheimer's Disease Phase III
    • 8.4.4.1. Alzheimer's Disease Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Alzheimer's Disease Phase IV
    • 8.4.5.1. Alzheimer's Disease Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Depression (MDD)
  • 8.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Depression (MDD) Phase I
    • 8.5.2.1. Depression (MDD) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Depression (MDD) Phase II
    • 8.5.3.1. Depression (MDD) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. Depression (MDD) Phase III
    • 8.5.4.1. Depression (MDD) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Depression (MDD) Phase IV
    • 8.5.5.1. Depression (MDD) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Parkinson's Disease (PD)
  • 8.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Parkinson's Disease (PD) Phase I
    • 8.6.2.1. Parkinson's Disease (PD) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Parkinson's Disease (PD) Phase II
    • 8.6.3.1. Parkinson's Disease (PD) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. Parkinson's Disease (PD) Phase III
    • 8.6.4.1. Parkinson's Disease (PD) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Parkinson's Disease (PD) Phase IV
    • 8.6.5.1. Parkinson's Disease (PD) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Epilepsy
  • 8.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Epilepsy Phase I
    • 8.7.2.1. Epilepsy Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Epilepsy Phase II
    • 8.7.3.1. Epilepsy Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. Epilepsy Phase III
    • 8.7.4.1. Epilepsy Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Epilepsy Phase IV
    • 8.7.5.1. Epilepsy Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Stroke
  • 8.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. Stroke Phase I
    • 8.8.2.1. Stroke Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Stroke Phase II
    • 8.8.3.1. Stroke Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. Stroke Phase III
    • 8.8.4.1. Stroke Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Stroke Phase IV
    • 8.8.5.1. Stroke Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.9. Traumatic Brain Injury (TBI)
  • 8.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.2. Traumatic Brain Injury (TBI) Phase I
    • 8.9.2.1. Traumatic Brain Injury (TBI) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.3. Traumatic Brain Injury (TBI) Phase II
    • 8.9.3.1. Traumatic Brain Injury (TBI) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.4. Traumatic Brain Injury (TBI) Phase III
    • 8.9.4.1. Traumatic Brain Injury (TBI) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.5. Traumatic Brain Injury (TBI) Phase IV
    • 8.9.5.1. Traumatic Brain Injury (TBI) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.10. Amyotrophic Lateral Sclerosis (ALS)
  • 8.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10.2. Amyotrophic Lateral Sclerosis (ALS) Phase I
    • 8.10.2.1. Amyotrophic Lateral Sclerosis (ALS) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10.3. Amyotrophic Lateral Sclerosis (ALS) Phase II
    • 8.10.3.1. Amyotrophic Lateral Sclerosis (ALS) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10.4. Amyotrophic Lateral Sclerosis (ALS) Phase III
    • 8.10.4.1. Amyotrophic Lateral Sclerosis (ALS) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10.5. Amyotrophic Lateral Sclerosis (ALS) Phase IV
    • 8.10.5.1. Amyotrophic Lateral Sclerosis (ALS) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.11. Huntington's Disease
  • 8.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11.2. Huntington's Disease Phase I
    • 8.11.2.1. Huntington's Disease Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11.3. Huntington's Disease Phase II
    • 8.11.3.1. Huntington's Disease Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11.4. Huntington's Disease Phase III
    • 8.11.4.1. Huntington's Disease Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11.5. Huntington's Disease Phase IV
    • 8.11.5.1. Huntington's Disease Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.12. Muscle Regeneration
  • 8.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.12.2. Muscle Regeneration Phase I
    • 8.12.2.1. Muscle Regeneration Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.12.3. Muscle Regeneration Phase II
    • 8.12.3.1. Muscle Regeneration Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.12.4. Muscle Regeneration Phase III
    • 8.12.4.1. Muscle Regeneration Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.12.5. Muscle Regeneration Phase IV
    • 8.12.5.1. Muscle Regeneration Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.13. Others
  • 8.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.13.2. Others Phase I
    • 8.13.2.1. Others Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.13.3. Others Phase II
    • 8.13.3.1. Others Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.13.4. Others Phase III
    • 8.13.4.1. Others Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.13.5. Others Phase IV
    • 8.13.5.1. Others Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Neurology Clinical Trials Market: Value Chain Estimates & Trend Analysis

• 9.1. Neurology Clinical Trials Market, By Value Chain: Segment Dashboard
• 9.2. Neurology Clinical Trials Market, By Value Chain: Movement Analysis
• 9.3. Neurology Clinical Trials Market Estimates & Forecasts, By Value Chain, 2018 - 2030 (USD Million)
• 9.4. In-house
  • 9.4.1. In-house Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.5. CROs
  • 9.5.1. CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.6. Investigator Sites/Clinical Sites
  • 9.6.1. Investigator Sites/Clinical Sites Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Neurology Clinical Trials Market: Regional Estimates & Trend Analysis

• 10.1. Regional Market Dashboard
• 10.2. Regional Market Share Analysis, 2024 & 2030
• 10.3. North America
  • 10.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.3.2. U.S
    • 10.3.2.1. Key Country Dynamics
    • 10.3.2.2. Competitive Scenario
    • 10.3.2.3. Regulatory Framework
    • 10.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.3.3. Canada
    • 10.3.3.1. Key Country Dynamics
    • 10.3.3.2. Competitive Scenario
    • 10.3.3.3. Regulatory Framework
    • 10.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.3.4. Mexico
    • 10.3.4.1. Key Country Dynamics
    • 10.3.4.2. Competitive Scenario
    • 10.3.4.3. Regulatory Framework
    • 10.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 10.4. Europe
  • 10.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4.2. UK
    • 10.4.2.1. Key Country Dynamics
    • 10.4.2.2. Competitive Scenario
    • 10.4.2.3. Regulatory Framework
    • 10.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4.3. Germany
    • 10.4.3.1. Key Country Dynamics
    • 10.4.3.2. Competitive Scenario
    • 10.4.3.3. Regulatory Framework
    • 10.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4.4. France
    • 10.4.4.1. Key Country Dynamics
    • 10.4.4.2. Competitive Scenario
    • 10.4.4.3. Regulatory Framework
    • 10.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4.5. Italy
    • 10.4.5.1. Key Country Dynamics
    • 10.4.5.2. Competitive Scenario
    • 10.4.5.3. Regulatory Framework
    • 10.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4.6. Spain
    • 10.4.6.1. Key Country Dynamics
    • 10.4.6.2. Competitive Scenario
    • 10.4.6.3. Regulatory Framework
    • 10.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4.7. Denmark
    • 10.4.7.1. Key Country Dynamics
    • 10.4.7.2. Competitive Scenario
    • 10.4.7.3. Regulatory Framework
    • 10.4.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4.8. Sweden
    • 10.4.8.1. Key Country Dynamics
    • 10.4.8.2. Competitive Scenario
    • 10.4.8.3. Regulatory Framework
    • 10.4.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4.9. Norway
    • 10.4.9.1. Key Country Dynamics
    • 10.4.9.2. Competitive Scenario
    • 10.4.9.3. Regulatory Framework
    • 10.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 10.5. Asia Pacific
  • 10.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.5.2. Japan
    • 10.5.2.1. Key Country Dynamics
    • 10.5.2.2. Competitive Scenario
    • 10.5.2.3. Regulatory Framework
    • 10.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.5.3. China
    • 10.5.3.1. Key Country Dynamics
    • 10.5.3.2. Competitive Scenario
    • 10.5.3.3. Regulatory Framework
    • 10.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.5.4. India
    • 10.5.4.1. Key Country Dynamics
    • 10.5.4.2. Competitive Scenario
    • 10.5.4.3. Regulatory Framework
    • 10.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.5.5. Thailand
    • 10.5.5.1. Key Country Dynamics
    • 10.5.5.2. Competitive Scenario
    • 10.5.5.3. Regulatory Framework
    • 10.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.5.6. South Korea
    • 10.5.6.1. Key Country Dynamics
    • 10.5.6.2. Competitive Scenario
    • 10.5.6.3. Regulatory Framework
    • 10.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.5.7. Australia
    • 10.5.7.1. Key Country Dynamics
    • 10.5.7.2. Competitive Scenario
    • 10.5.7.3. Regulatory Framework
    • 10.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 10.6. Latin America
  • 10.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.6.2. Brazil
    • 10.6.2.1. Key Country Dynamics
    • 10.6.2.2. Competitive Scenario
    • 10.6.2.3. Regulatory Framework
    • 10.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.6.3. Argentina
    • 10.6.3.1. Key Country Dynamics
    • 10.6.3.2. Competitive Scenario
    • 10.6.3.3. Regulatory Framework
    • 10.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 10.7. MEA
  • 10.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.7.2. South Africa
    • 10.7.2.1. Key Country Dynamics
    • 10.7.2.2. Competitive Scenario
    • 10.7.2.3. Regulatory Framework
    • 10.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.7.3. Saudi Arabia
    • 10.7.3.1. Key Country Dynamics
    • 10.7.3.2. Competitive Scenario
    • 10.7.3.3. Regulatory Framework
    • 10.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.7.4. UAE
    • 10.7.4.1. Key Country Dynamics
    • 10.7.4.2. Competitive Scenario
    • 10.7.4.3. Regulatory Framework
    • 10.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.7.5. Kuwait
    • 10.7.5.1. Key Country Dynamics
    • 10.7.5.2. Competitive Scenario
    • 10.7.5.3. Regulatory Framework
    • 10.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)